Moscow, July 9, 2013, – OJSC Pharmstandard (Pharmstandard JSC (LSE: PHST IL, MICEX\RTS (main):PHST, MICEX\RTS (classica):PHST) will hold an Investor Conference with regards to the details of the announced spin-off process.

Wednesday, July 10, 2013at 17:00 Moscow time.

Pharmstandard takes pleasure to invite the investment community to participate in Pharmstandard Investor Conference Call with the management of the company followed by a Q&A session.

 Wednesday, July 10, 2013

09:00 New York

14:00 London

17:00 Moscow
Participant Access 

Confirmation Code:7261355 

LONDON  UNITED KINGDOM, Local: +44(0)20 3427 1907

NEW YORK  UNITED STATES OF AMERICA, Local: +1718 971 5738

RUSSIAN FEDERATION, Freephone: +7495 705 9450

Please, dial in 5-10 minutes prior to the start time using the number / Confirmation Code above 

Conference call presentation will be available onWednesday, July 10, 2013
on Company’s web-site at 15:00 Moscow time.

https://pharmstd.com/
Pharmstandard will be represented by:

Igor Krylov, CEO

Elena Arkhangelskaya, CFO
Irina Bakhturina, IR

The conference call replay will be available through July 14, 2013

LONDON  UNITED KINGDOM, Local: +44 (0)20 3427 0598

NEW YORK  UNITED STATES OF AMERICA, Local: +1 347 366 9565

RUSSIAN FEDERATION, Freephone: 810 800 2870 1012

Replay Access Code: 7261355

Contacts:

Irina Bakhturina
Investor Relations
Pharmstandard OJSC
Tel.: +7 (495) 970-0030 Ext.2824
E-mail: ir@pharmstd.ru
www.pharmstd.com